Identification of side effects of COVID-19 drug candidates on embryogenesis using an integrated zebrafish screening platform
Open Access
- 9 October 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-19
Abstract
Drug repurposing is an important strategy in COVID-19 treatment, but many clinically approved compounds have not been extensively studied in the context of embryogenesis, thus limiting their administration during pregnancy. Here we used the zebrafish embryo model organism to test the effects of 162 marketed drugs on cardiovascular development. Among the compounds used in the clinic for COVD-19 treatment, we found that Remdesivir led to reduced body size and heart functionality at clinically relevant doses. Ritonavir and Baricitinib showed reduced heart functionality and Molnupiravir and Baricitinib showed effects on embryo activity. Sabizabulin was highly toxic at concentrations only 5 times higher than Cmax and led to a mean mortality of 20% at Cmax. Furthermore, we tested if zebrafish could be used as a model to study inflammatory response in response to spike protein treatment and found that Remdesivir, Ritonavir, Molnupiravir, Baricitinib as well as Sabizabulin counteracted the inflammatory response related gene expression upon SARS-CoV-2 spike protein treatment. Our results show that the zebrafish allows to study immune-modulating properties of COVID-19 compounds and highlights the need to rule out secondary defects of compound treatment on embryogenesis. All results are available on a user friendly web-interface https://share.streamlit.io/alernst/covasc_dataapp/main/CoVasc_DataApp.py that provides a comprehensive overview of all observed phenotypic effects and allows personalized search on specific compounds or group of compounds. Furthermore, the presented platform can be expanded for rapid detection of developmental side effects of new compounds for treatment of COVID-19 and further viral infectious diseases.Keywords
All Related Versions
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_189136, 4078P0_198297)
This publication has 66 references indexed in Scilit:
- Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndromeeneuro, 2015
- Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discoveryDrug Design, Development and Therapy, 2014
- Developmental toxicity assay using high content screening of zebrafish embryosJournal of Applied Toxicology, 2014
- Development of an Automated Imaging Pipeline for the Analysis of the Zebrafish Larval KidneyPLOS ONE, 2013
- Vascular Development in the ZebrafishCold Spring Harbor Perspectives in Medicine, 2012
- Zebrafish: Model for the Study of Inflammation and the Innate Immune Response to Infectious Diseases2011
- Automated image‐based phenotypic analysis in zebrafish embryosDevelopmental Dynamics, 2009
- Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasisNature, 2007
- Heart and soul/PRKCi and nagie oko/Mpp5 regulate myocardial coherence and remodeling during cardiac morphogenesisDevelopment, 2006
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995